Skip to main content
. 2021 Mar 15;13(6):1304. doi: 10.3390/cancers13061304

Figure 4.

Figure 4

First-line treatment options for fit patients with metastatic or unresectable gastric or gastroesophageal junction adenocarcinoma. FLOT, 5-fluorouracil/leucovorin, oxaliplatin, and docetaxel; MSI, microsatellite instability.